<DOC>
	<DOCNO>NCT00015899</DOCNO>
	<brief_summary>RATIONALE : SCH 66336 may stop growth tumor cell block enzymes necessary cancer cell growth . PURPOSE : This phase I trial study side effect best dose SCH 66336 treat child recurrent progressive brain tumor .</brief_summary>
	<brief_title>SCH 66336 Treating Children With Recurrent Progressive Brain Tumors</brief_title>
	<detailed_description>OBJECTIVES : - Determine qualitative quantitative toxicity SCH 66336 child recurrent progressive brain tumor . - Estimate maximum tolerate dose drug patient . - Describe pharmacokinetics drug without dexamethasone patient . - Investigate efficacy drug patient . OUTLINE : This dose-escalation study . Patients receive oral SCH 66336 twice daily . Treatment repeat every 4 week total 26 course absence disease progression unacceptable toxicity . Cohorts 1-6 patient receive escalate dos SCH 66336 maximum tolerate dose ( MTD ) determine . The MTD define dose predict 20 % patient may experience dose-limiting toxicity . An additional 6 patient treat determined MTD . Patients follow within 30 day last administration study drug 3 month . PROJECTED ACCRUAL : Approximately 25 patient accrue study .</detailed_description>
	<mesh_term>Brain Neoplasms</mesh_term>
	<mesh_term>Nervous System Neoplasms</mesh_term>
	<mesh_term>Central Nervous System Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm recurrent progressive ( refractory ) brain tumor Histologic confirmation waive brainstem glioma Bone marrow involvement allow transfusion independent PATIENT CHARACTERISTICS : Age : 21 Performance status : Lansky 60100 % OR Karnofsky 60100 % Life expectancy : More 8 week Hematopoietic : See Disease Characteristics Absolute neutrophil count great 1,000/mm^3 Platelet count great 75,000/mm^3 Hemoglobin great 9 g/dL Hepatic : Bilirubin great upper limit normal SGPT SGOT less 2.5 time normal Albumin great 3 g/dL PT/PTT great 120 % upper limit normal No overt hepatic disease Renal : Creatinine great 1.5 time normal OR Glomerular filtration rate great 70 mL/min No overt renal disease Cardiovascular : No overt cardiac disease Pulmonary : No overt pulmonary disease Other : Neurologic deficit allow stable least 1 week prior study More 3rd percentile weight height Able swallow pills No uncontrolled infection No known suspect allergy poloxamer 188 , croscarmellose sodium , silicon dioxide , magnesium stearate I Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception 10 week study PRIOR CONCURRENT THERAPY : Biologic therapy : More 6 month since prior bone marrow transplantation More 1 week since prior growth factor Chemotherapy : At least 3 week since prior myelosuppressive chemotherapy ( 6 week nitrosoureas ) recover Endocrine therapy : Concurrent dexamethasone allow stable dose least 1 week prior study Concurrent oral contraceptive hormonal contraceptive method allow Radiotherapy : More 6 week since prior substantial bone marrow radiotherapy More 3 month since prior craniospinal radiotherapy ( 24 Gy ) total body irradiation More 2 week since prior focal radiotherapy symptomatic metastatic site Surgery : Not specify Other : No concurrent enzymeinducing anticonvulsant drug No concurrent anticancer experimental drug therapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>childhood craniopharyngioma</keyword>
	<keyword>childhood central nervous system germ cell tumor</keyword>
	<keyword>childhood oligodendroglioma</keyword>
	<keyword>childhood choroid plexus tumor</keyword>
	<keyword>childhood grade I meningioma</keyword>
	<keyword>childhood grade II meningioma</keyword>
	<keyword>childhood grade III meningioma</keyword>
	<keyword>recurrent childhood cerebellar astrocytoma</keyword>
	<keyword>recurrent childhood cerebral astrocytoma</keyword>
	<keyword>recurrent childhood medulloblastoma</keyword>
	<keyword>recurrent childhood visual pathway hypothalamic glioma</keyword>
	<keyword>recurrent childhood ependymoma</keyword>
	<keyword>childhood atypical teratoid/rhabdoid tumor</keyword>
	<keyword>childhood spinal cord neoplasm</keyword>
</DOC>